RCM Technologies RCMT Specialty Health Care — Depreciation Nonproduction
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by RCM Technologies in its filing.
Tagged under the XBRL concept us-gaap:DepreciationNonproduction.
The official record: RCM Technologies’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about RCM Technologies's specialty health care — depreciation nonproduction.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is RCM Technologies's specialty health care — depreciation nonproduction?
- RCM Technologies (RCMT) reported specialty health care — depreciation nonproduction of $122K in Q1 2026.
- How has RCM Technologies's specialty health care — depreciation nonproduction changed year-over-year?
- RCM Technologies's specialty health care — depreciation nonproduction increased by 22.0% year-over-year, from $100K to $122K.
- What is the long-term trend for RCM Technologies's specialty health care — depreciation nonproduction?
- Over 4 years (2021 to 2025), RCM Technologies's specialty health care — depreciation nonproduction has grown at a 1.2% compound annual growth rate (CAGR), from $374K to $393K.
- What does specialty health care — depreciation nonproduction mean?
- The systematic allocation of the cost of tangible assets, such as office equipment or technology infrastructure, that are not directly involved in the production of services within the Specialty Health Care segment. This expense reflects the consumption of long-term assets used to support administrative and general operations. It is a non-cash charge that impacts the segment's reported operating income.